VISIOPHARM CORPORATION

Visiopharm Corporation specializes in advanced digital pathology and image analysis software solutions for federal health agencies, with a focus on AI-driven histopathological analysis and subscription-based diagnostic platforms. Their core capabilities center on developing and deploying proprietary software that automates tissue image interpretation, enabling quantitative pathology workflows for research and clinical decision support. The company’s technical expertise includes computational histology, machine learning for cellular segmentation, and high-throughput image processing systems tailored to medical imaging standards. Key differentiators lie in their domain-specific algorithms for tissue classification and their ability to integrate seamlessly with laboratory information systems, providing scalable, regulatory-compliant tools for precision medicine applications. Visiopharm maintains a strong, sustained relationship with the Department of Health and Human Services, delivering software upgrades, maintenance, and AI-powered analytical tools for public health and biomedical research initiatives. They also support the Department of Veterans Affairs with specialized computer services, indicating a focus on veteran healthcare analytics and diagnostic infrastructure modernization. The contractor’s primary industry focus is software publishing for health science applications, particularly in digital pathology and medical image analysis. While occasional contracts fall under miscellaneous manufacturing, these reflect the physical or embedded nature of their software deployment systems, not hardware production. Visiopharm is positioned as a niche provider of FDA-regulated diagnostic software tools, serving the growing demand for AI-augmented pathology in federal biomedical programs. Visiopharm Corporation is a small business entity based in Broomfield, Colorado, with no government certifications on record. Its market presence is defined by deep technical specialization rather than broad compliance credentials, allowing it to serve federal health agencies with targeted, high-accuracy imaging solutions. The company’s geographic location supports its focus on federal R&D and public health contracting ecosystems.